Anti-Protease Activity Deficient Secretory Leukocyte Protease Inhibitor (SLPI) Exerts Cardioprotective Effect against Myocardial Ischaemia/Reperfusion

Inhibition of proteases shows therapeutic potential. Our previous studies demonstrated the cardioprotection by the Secretory Leukocyte Protease Inhibitor (SLPI) against myocardial ischaemia/reperfusion (I/R) injury. However, it is unclear whether the cardioprotective effect of SLPI seen in our previ...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Podsawee Mongkolpathumrat, Anusak Kijtawornrat, Eukote Suwan, Sasimanas Unajak, Aussara Panya, Tonapha Pusadee, Sarawut Kumphune
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2022-04-01
סדרה:	Biomedicines
נושאים:	myocardial ischaemia/reperfusion injury SLPI cardioprotection protease activity anti-protease deficient
גישה מקוונת:	https://www.mdpi.com/2227-9059/10/5/988
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!